Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dossenbach

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Wiener Klinische Wochenschrift|January 1, 1991
[Efficacy and safety of fluoxetine versus clomipramine in ambulatory patients with a depressive syndrome in a clinical trial with private practitioners]G Pakesch, M Dossenbach
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 22, 2001
Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profileF Martényi, M Dossenbach, K Mraz, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1992
[Concomitant depression and its treatment]C Kaufmann, P Panayiotou, M Dossenbach, et al.
Wiener Klinische Wochenschrift|July 27, 1999
Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorderW Zitterl, K Meszaros, K Hornik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2021
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion methodU Mrowietz, R B Warren, C L Leonardi, et al.
International Journal of Clinical Practice|September 29, 2009
Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patientsJ Karagianis, D Novick, J Pecenak, et al.
The British Journal of Dermatology|August 4, 2019
A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatmentK Reich, M Augustin, D Thaçi, et al.
International Journal of Geriatric Psychiatry|November 18, 2003
Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trialJ S Kennedy, D Jeste, C J Kaiser, et al.
International Journal of Clinical Practice|July 3, 2009
Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational studyQ Q Ang, Y K Wing, Y He, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataJ S Kennedy, F P Bymaster, L Schuh, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Wiener Klinische Wochenschrift|January 1, 1991
[Efficacy and safety of fluoxetine versus clomipramine in ambulatory patients with a depressive syndrome in a clinical trial with private practitioners]G Pakesch, M Dossenbach
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 22, 2001
Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profileF Martényi, M Dossenbach, K Mraz, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1992
[Concomitant depression and its treatment]C Kaufmann, P Panayiotou, M Dossenbach, et al.
Wiener Klinische Wochenschrift|July 27, 1999
Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorderW Zitterl, K Meszaros, K Hornik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2021
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion methodU Mrowietz, R B Warren, C L Leonardi, et al.
International Journal of Clinical Practice|September 29, 2009
Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patientsJ Karagianis, D Novick, J Pecenak, et al.
The British Journal of Dermatology|August 4, 2019
A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatmentK Reich, M Augustin, D Thaçi, et al.
International Journal of Geriatric Psychiatry|November 18, 2003
Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trialJ S Kennedy, D Jeste, C J Kaiser, et al.
International Journal of Clinical Practice|July 3, 2009
Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational studyQ Q Ang, Y K Wing, Y He, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataJ S Kennedy, F P Bymaster, L Schuh, et al.
Pageof 1